Adiponectin an adipocyte-derived hormone may therefore have the potential to provide an important therapeutic tool to reduce the burden associated with obesity and related chronic diseases including diabetes and cardiovascular disease (CVD). This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.